M. Gunasena

Evaluation of early innate and adaptive immune responses to the TB vaccine Mycobacterium bovis BCG and vaccine candidate BCGΔBCG1419c

K. Oestreich, Kenneth J. Oestreich, Michael D. Powell, 2021, Scientific Reports.

TREATMENT WITH SOLUBLE CD24 ATTENUATES COVID-19-ASSOCIATED SYSTEMIC IMMUNOPATHOLOGY

Dongjun Chung, C. Bolyard, Qin Ma, 2021, Journal of Hematology & Oncology.

TREATMENT WITH SOLUBLE CD24 ATTENUATES COVID-19-ASSOCIATED SYSTEMIC IMMUNOPATHOLOGY

Dongjun Chung, Mohammad Yusuf, C. Bolyard, 2021, medRxiv.

Evaluation of Early Innate and Adaptive Immune Responses to the TB Vaccine Mycobacterium Bovis BCG and Vaccine Candidate BCGdBCG1419c

M. Gunasena, R. Shukla, Mario Alberto Florez Valdez, 2021 .

Treatment with soluble CD24 attenuates COVID-19-associated systemic immunopathology

Anqi Li, Yuzhou Chang, Zequn Sun, 2022, Journal of Hematology & Oncology.

Unveiling the immune dynamics of Neisseria persistent oral colonization

A. Wijeratne, D. Kasturiratna, M. Gunasena, 2023, bioRxiv.

BCG immunization induced KLRG1+ NK cells show memory-like responses to mycobacterial and HIV antigens

M. Gunasena, M. Alles, W. Mulhern, 2024, bioRxiv.

Novel Oral Adjuvant to Enhance Cytotoxic Memory-Like NK Cell Responses in an HIV Vaccine Platform

M. Gunasena, M. Alles, W. Mulhern, 2024, bioRxiv.